Company profile

DR REDDYS LABORATORIES LTD

NYSE:RDYBiotechnology: Pharmaceutical Preparations

Drug pipeline (325)

AssetStageRevenueTrialsStatus
ABIRATERONE ACETATEapproved—26approved
ACETAMINOPHEN AND IBUPROFENapproved—86approved
ACYCLOVIR SODIUMapproved—1approved
ALBENDAZOLEapproved—0—
AMIODARONE HYDROCHLORIDEapproved—0—

Revenue is the latest quarter the company reported for that product, from SEC filings; a fourth quarter is the year less nine months when no filing states one. Trial counts are of the product's ingredients, deduplicated by trial, so products sharing an ingredient share trials.

Clinical trials (223)

NCT IDPhaseStatusStartCompletionSponsor nameTitle
NCT03599193phase2completed2017-10-042018-04-30Dr. Reddy's Laboratories LimitedA Bioavailability Study of DFD-03 Compared to Tazorac® in Patients With Moderate Acne Vulgaris
NCT06193187phase1unknown2024-01-012024-03-01Dr. Reddy's Laboratories (Thailand) LimitedA Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions
NCT02205320phase1unknown2014-02-012014-08-01Dr. Reddy's Laboratories LimitedA Comparative, Crossover, Pharmacokinetic, Pharmacodynamic and Safety Study of Three Forms of PEG-G-CSF in Normal Healthy Volunteers
NCT03340961phase2completed2017-10-012018-11-07Dr. Reddy's Laboratories LimitedA Controlled Study to Assess the Efficacy, Safety and Tolerability of Oral DFD-29 Extended Release Capsules
NCT02010333phase2completed2013-04-012014-07-01Dr. Reddy's Laboratories LimitedA Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice Infestation

FDA applications (403)

ApplicationApprovedTypeApplicantProducts
ANDA 2132342026-08-31ANDADR REDDYS LABORATORIES LTD
ANDA 2204482026-08-06ANDADR REDDYS LABORATORIES LTD
BLA 7613762026-07-31BLADR. REDDY'S LABORATORIES SA
ANDA 2204132026-07-30ANDADR REDDYS LABORATORIES LTD
ANDA 2142362026-07-28ANDADR REDDYS LABORATORIES LTD